Demand for addiction treatment remains strong. New programs keep entering the market, and private equity continues to acquire promising treatment organizations in pursuit of growth. So why do so many programs still struggle to maintain profitability and deliver the returns their owners and investors expect?

A recent survey of community-based behavioral health providers found 22 organizations running 39 substance use disorder programs at a deficit, and more than half of respondents had less than three months of cash on hand. These were not failing organizations. Many had respected brands, strong clinical leadership, active admissions teams, and a steady flow of patients.

For owners, executive teams, and investors, three issues quietly undermine otherwise strong operations: patient bad debt, unpredictable insurance reimbursement, and patients leaving too soon. Programs have long accepted all three as the cost of doing business. Left unmanaged, they erode margins, destabilize cash flow, and can threaten the viability of a well-run organization.

1. Patient bad debt erodes the value of an admission

Insurance coverage does not mean treatment is paid for. Patients and families remain responsible for deductibles, coinsurance, copayments, and other out-of-pocket costs, and over a residential stay that responsibility can be substantial.

Consider John. The allowed cost of his residential treatment is $20,000, but he has not met his $5,000 deductible. After the deductible, his plan covers 60% of the remaining balance. The insurer pays $9,000. John owes $11,000. The program puts him on a payment plan, which is not the same as collecting.

FinPay, drawing on more than $500 million in patient financial responsibility across 100-plus treatment facilities and 220,000 patients, reports that behavioral health providers collect an average of only 13% to 15% of what patients owe. On paper, John is a $20,000 admission. In practice, the program books the insurer’s $9,000 and a small fraction of John’s $11,000.

Programs are effectively discounting the value of treatment, even with insurance, because payment from the patient is most often not going to arrive.

2. Insurance reimbursement is less predictable than it looks

A patient arrives with verified benefits and an initial authorization. That does not guarantee payment for the expected course of treatment. Payers may shorten authorizations or deny additional days, delay claims or downcode services to lower-paying levels, and challenge documentation or lean on contractual provisions to reduce payment.

Because billing is complex, programs often pay third-party billing and collection fees just to secure reimbursement they are owed. An attractive daily rate becomes far less meaningful after shortened authorizations, billing costs, patient bad debt, payment delays, and reduced claims. For executives and investors, payer mix is a strategic issue, not a billing-department issue.

3. Patients leaving too soon can break the economics of a program

A program can generate enough admissions and still underperform when too many patients leave before completing the expected course of care. When a patient leaves against medical or clinical advice, the program loses the remaining revenue from that stay, absorbs the cost of replacing the patient, and continues covering largely fixed operating expenses on a lower census. (The full math is in The Census Leak.)

Consider John again. He is a week into residential, adjusting to life without substances and struggling with the structure. When he gets phone privileges, he calls home: his therapist doesn’t understand him, the food is terrible, he is nothing like the other patients. He begs his family to pick him up. Unprepared for the call, and used to giving in during a crisis, they agree.

Research suggests roughly one in five patients leaves addiction treatment against medical or clinical advice, with reported rates generally ranging from 15% to 25% depending on setting and population. A program with strong admissions and weak retention looks healthy at the top of the funnel while losing revenue, margin, and clinical value downstream.

Two ways to protect the financial value of an admission

Programs cannot eliminate every source of financial uncertainty. But two of the three risks above — unpaid patient balances and premature discharge — can be materially reduced with models that already exist.

Remove the patient’s financial burden

New referral and payment models are changing how treatment is funded. Carrum Health, for example, connects eligible employees and their families with selected treatment providers through an employer-sponsored benefit. Under this model the patient’s deductible, copay, and coinsurance are removed. Patients enter treatment without taking on thousands of dollars in personal debt. Providers avoid collecting from patients and gain a more predictable payment than a traditional insurance admission burdened by deductibles, billing fees, delays, denials, and collection risk.

The model also reduces much of the administrative friction of traditional insurance: ongoing authorization disputes, negotiations over lower levels of care, and claims billing. (This is also why employer and Center of Excellence channels are becoming a growth strategy in their own right — see what those partners ask providers to prove.)

Compare the expected revenue from a traditional insurance admission with a Carrum Health referral using the calculator.

Keep patients engaged in treatment

Programs invest heavily in acquiring patients and far less in protecting the admission once treatment begins. Families are usually the first call when a patient wants to leave. Without preparation, they may not understand what the patient is experiencing, how to respond, or how to support the treatment team.

Pathroot Health was built to address that gap by aligning families with the treatment process from day one. Its fully managed virtual program sets expectations about treatment, teaches families how to hold appropriate boundaries, prepares them to respond when a patient threatens to leave, and surfaces concerns before they escalate into an early discharge. The goal is not to make families responsible for retention. It is to turn an influential, often unprepared stakeholder into an informed partner in care.

See what premature discharges may be costing your program in lost treatment days, lower census, and replacement cost with the AMA Impact Calculator.

Financial instability is not inevitable

Patient bad debt and premature discharge have long been treated as unavoidable realities of addiction treatment. They should not be ignored because they are common. New payment models can reduce the burden on patients and improve revenue predictability. Better family alignment can keep patients engaged long enough to receive the care they need.

For owners, executive teams, and investors, the opportunity is clear: protecting the financial value of an admission may be as important as generating the admission in the first place.

Frequently Asked Questions

Why do addiction treatment programs lose money even with strong admissions?

Three risks erode revenue after the admission: patient bad debt on deductibles and coinsurance, unpredictable insurance reimbursement from shortened authorizations, delays, downcoding, and denials, and patients leaving treatment early. A program can fill beds and still underperform financially if these are not actively managed.

How much of patient financial responsibility do treatment programs actually collect?

According to FinPay, drawing on more than $500 million in patient financial responsibility across more than 100 treatment facilities and 220,000 patients, behavioral health providers collect an average of only 13% to 15% of what patients owe in deductibles, coinsurance, and copays.

What percentage of patients leave addiction treatment against medical advice?

Research suggests roughly one in five patients leaves addiction treatment against medical or clinical advice, with reported rates generally ranging from 15% to 25% depending on the setting and patient population.

How does a Carrum Health referral change the economics of an admission?

Under Carrum Health’s employer-sponsored model, the patient’s deductible, copay, and coinsurance are removed, so the provider is not dependent on collecting from the patient and receives a more predictable payment than a traditional insurance admission. It also reduces authorization disputes, level-of-care negotiations, and claims billing. Pathroot’s Carrum vs. insurance calculator compares expected revenue under both models.

How does family engagement protect the financial value of an admission?

Families are usually the first call when a patient wants to leave treatment early. Preparing families before that call, setting expectations, teaching boundaries, and surfacing concerns early makes them an aligned partner in care rather than the reason a patient leaves, which protects the remaining revenue of the stay and the census.

What does the AMA Impact Calculator measure?

Pathroot’s AMA Impact Calculator estimates what premature discharges may be costing a program through lost treatment days, lower census, and the expense of replacing the patient, based on the program’s own volume, rates, and early-exit percentage.

Why is payer mix a strategic issue rather than a billing issue?

An attractive daily rate can be substantially reduced by shortened authorizations, billing and collection fees, patient bad debt, payment delays, and denied or downcoded claims. Because these factors determine the revenue a program actually collects per admission, decisions about payer mix and referral channels directly affect margin and cash flow.

Sources

• FinPay, behavioral health patient financial responsibility data (more than $500M across 100+ facilities and 220,000 patients)

• Survey of community-based behavioral health providers on SUD program financial performance and cash reserves (2025–2026)

• Choi, M., et al. (2013). Readmission rates of patients discharged against medical advice: a matched cohort study. PLOS ONE

• Agency for Healthcare Research and Quality, Patient Safety Network: Discharge Against Medical Advice

• SAMHSA, Treatment Episode Data Set (TEDS): Admissions and Discharges from Publicly Funded Substance Use Treatment

• Carrum Health, Centers of Excellence program overview

• SAMHSA, Treatment Improvement Protocol (TIP) 39: Substance Use Disorder Treatment and Family Therapy (updated 2020)

• Stanton, M.D., & Shadish, W.R. (1997). Outcome, attrition, and family-couples treatment for drug abuse: a meta-analysis and review of the controlled, comparative studies. Psychological Bulletin, 122(2), 170–191